Why Market Size Forecasters?
- Reports at Lowest Prices - Guaranteed
- Fastest Growing Research Reports’ Database
- Easy Customization Options
- 24 X 7 Support Commitment
- Certified, Safe & Secured Payments
About Sexually Transmitted Diseases Testing STDs, also known as STIs, are infectious diseases caused by bacteria, yeast, parasites, and viruses, and are transmitted through sexual contact, thus generating the need for STD testing and demand for devices used for testing. Technavios analysts forecast the global sexually transmitted diseases testing market to grow at a CAGR of 8.61% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the global sexually transmitted diseases testing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The market is divided into the following segments based on geography: Americas APAC EMEA Technavio's report, Global Sexually Transmitted Diseases Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors Abbott bioMerieux Bio-Rad Laboratories F. Hoffmann La Roche Market driver Rise in STDs For a full, detailed list, view our report Market challenge Lack of trained professionals For a full, detailed list, view our report Market trend High demand for POC testing For a full, detailed list, view our report Key questions answered in this report What will the market size be in 2022 and what will the growth rate be? What are the key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 05: MARKET SIZING Global STD testing market overview Market sizing 2017 Global STD testing market PART 06: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 07: MARKET SEGMENTATION BY TESTING DEVICES Global STD testing market by testing devices Comparison by testing devices Global STD testing market by laboratory testing devices Global STD testing market by POC testing devices Market opportunity by testing devices PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE Geographical segmentation Regional comparison STD testing market in Americas STD testing market in EMEA STD testing market in APAC Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES Market drivers Market challenges PART 12: MARKET TRENDS High demand for POC testing Rising awareness regarding HIV Increasing importance of promotional activities PART 13: VENDOR LANDSCAPE Overview Landscape disruption PART 14: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors Abbott bioMerieux Bio-Rad Laboratories F. Hoffmann La Roche Other prominent vendors Company Description PART 15: APPENDIX List of abbreviations List of Exhibits Exhibit 01: Related market Exhibit 02: Market characteristics Exhibit 03: Market segments Exhibit 04: Market definition: Inclusions and exclusions checklist Exhibit 05: Validation techniques employed for market sizing 2017 Exhibit 06: Global STD testing market 2017-2022 ($ billions) Exhibit 07: Global STD testing market: Year-over-year (YoY) growth 2018-2022 (%) Exhibit 08: Five forces analysis 2017 Exhibit 09: Five forces analysis 2022 Exhibit 10: Bargaining power of buyers Exhibit 11: Bargaining power of suppliers Exhibit 12: Threat of new entrants Exhibit 13: Threat of substitutes Exhibit 14: Threat of rivalry Exhibit 15: Market condition: Five forces 2017 Exhibit 16: Market condition: Five forces 2022 Exhibit 17: Global STD testing market by testing devices 2017-2022 (%) Exhibit 18: Comparison by testing devices Exhibit 19: Global STD testing market by laboratory testing devices 2017-2022 ($ billions) Exhibit 20: Global STD testing market by laboratory testing devices: YoY growth 2018-2022 (%) Exhibit 21: Global STD testing market by POC testing devices 2017-2022 ($ billions) Exhibit 22: Global STD testing market by POC testing devices: YoY growth 2018-2022 (%) Exhibit 23: Market opportunity by testing devices Exhibit 24: Customer landscape Exhibit 25: Global STD testing market by geography 2017-2022 (%) Exhibit 26: Regional comparison Exhibit 27: STD testing market in Americas 2017-2022 ($ billions) Exhibit 28: Americas: YoY growth 2018-2022 (%) Exhibit 29: Top three countries in Americas Exhibit 30: STD testing market in EMEA 2017-2022 ($ billions) Exhibit 31: STD testing market in EMEA: YoY growth 2018-2022 (%) Exhibit 32: Top three countries in EMEA Exhibit 33: STD testing market in APAC 2017-2022 ($ billions) Exhibit 34: STD testing market in APAC: YoY growth 2018-2022 (%) Exhibit 35: Top three countries in APAC Exhibit 36: Market opportunity Exhibit 37: Vendor landscape Exhibit 38: Landscape disruption Exhibit 39: Vendors covered Exhibit 40: Vendor classification Exhibit 41: Market positioning of vendors Exhibit 42: Vendor overview Exhibit 43: Abbott: Business segments Exhibit 44: Abbott: Organizational developments Exhibit 45: Abbott: Geographic focus Exhibit 46: Abbott: Segment focus Exhibit 47: Abbott: Key offerings Exhibit 48: Vendor overview Exhibit 49: bioMerieux: Business segments Exhibit 50: bioMerieux: Organizational developments Exhibit 51: bioMerieux: Geographic focus Exhibit 52: bioMerieux: Segment focus Exhibit 53: bioMerieux: Key offerings Exhibit 54: Vendor overview Exhibit 55: Bio-Rad laboratories: Business segments Exhibit 56: Bio-Rad laboratories: Organizational developments Exhibit 57: Bio-Rad Laboratories: Geographic focus Exhibit 58: Bio-Rad Laboratories: Segment focus Exhibit 59: Bio-Rad laboratories: Key offerings Exhibit 60: Vendor overview Exhibit 61: F. Hoffmann La Roche: Business segments Exhibit 62: F. Hoffmann La Roche: Organizational developments Exhibit 63: F. Hoffmann La Roche: Geographic focus Exhibit 64: F. Hoffmann La Roche: Segment focus Exhibit 65: F. Hoffmann La Roche: Key offerings
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary research - Manufacturers/Suppliers, Channel partners, Industry experts, Strategic decision makers
Secondary research - Technavio internal repository, Industry journals and periodicals, Government bodies, Annual reports of key stakeholders
Data synthesis - Collation of data, Estimation of key figure, Analysis of derived insights
Data validation - Triangulation with data models, Reference against proprietary databases, Corroboration with industry experts
Qualitative analysis - Market drivers, Market challenges, Market trends, Five forces analysis
Quantitative analysis- Market size and forecast, Market segmentation, Geographical insights, Competitive landscape
Technavio’s database and industry-specific repositories are used for defining the hypothesis for the study, which is further fine-tuned through primary research involving industry experts. The success of our approach lies in the fact that we take the viewpoint of all stakeholders into consideration while analyzing an industry, and objectively assess each outlook.
Why Market Size Forecasters?